Drug class in one race
EGFR x 4-1BB (CD137) drugs for Non-Small Cell Lung Cancer
2 tracked EGFR x 4-1BB (CD137) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the EGFR x 4-1BB (CD137) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 11 preclinical / unstaged
Head-to-head evidence: HLX35 vs YH32364